Iron deficiency is a potent stimulator of fibroblast growth factor 23 (FGF23), a hormonal
regulator of phosphate and vitamin D metabolism, that is classically thought to be produced …

Circulating levels of fibroblast growth factor 23 (FGF23) are elevated in patients with chronic
kidney disease (CKD), but the mechanisms are poorly understood. Here we tested whether …

Abstract Fibroblast Growth Factor 23 (FGF23) is a phosphaturic factor causing increased
renal phosphate excretion as well as suppression of 1, 25 (OH) 2-vitamin D3. Highly …

Abstract Fibroblast growth factor 23 (FGF23) is a major endocrine regulator of phosphate
and 1, 25 (OH) 2 vitamin D 3 metabolism and is mainly produced by osteocytes. Its …

Abstract Purpose of Review Fibroblast growth factor-23 (FGF23) is the key hormone
produced in bone critical for phosphate homeostasis. Elevated serum phosphorus and 1, 25 …

Abnormal blood cell production is associated with chronic kidney disease (CKD) and
cardiovascular disease (CVD). Bone-derived FGF-23 (fibroblast growth factor-23) regulates …

Abstract Fibroblast growth factor 23 (FGF-23) hormone is produced by bone-embedded
osteocytes and regulates phosphate homeostasis in kidneys. We found that administration …

Abstract Fibroblast growth factor 23 (FGF23) plays an important role in the development of
chronic kidney disease‑mineral bone disorder (CKD‑MBD). Abnormally elevated levels of 1 …

Iron deficiency stimulates FGF23 production, but normal osteocytes couple increased FGF23
production with increased cleavage to maintain normal circulating levels of biologically …

ABSTRACT Fibroblast growth factor 23 (FGF23) is an osteocyte‐derived hormone that
regulates phosphate and vitamin D homeostasis. Through unknown mechanisms, certain …